Introduction Semaglutide is rapidly emerging as a revolutionary medication in the treatment of type 2 diabetes, obesity, and related cardiovascular conditions. Initially designed to improve blood sugar control in people with type 2 diabetes, Semaglutide is a part of the GLP-1 (glucagon-like peptide-1) receptor agonists class of drugs. This class https://dna-testing-services-in-i48158.shopping-wiki.com/8793958/semaglutide_a_breakthrough_in_managing_diabetes_weight_and_heart_health